Microplastics and Nanoplastics: What We Know About Sources, Body Burden, and Emerging Health Risks

Microplastics — plastic fragments smaller than 5 mm — and their smaller siblings nanoplastics (smaller than 1 µm) are now found in essentially every environmental compartment measured and nearly every human tissue sampled. In just the past two years, studies have documented microplastics in blood, lungs, placenta, testes, breast milk, liver, kidney, and atherosclerotic plaque. A landmark 2024 paper in the New England Journal of Medicine linked the presence of microplastics in carotid-artery plaque to a 4.5-fold higher risk of heart attack, stroke, or death over three years. The research is moving rapidly, and while many mechanisms remain provisional, the cumulative picture warrants taking exposure reduction seriously.

This article explains what microplastics and nanoplastics are, where they come from, how they enter the body, what is known about their health effects, and the evidence-informed steps an individual can take to reduce exposure without chasing impossible zero.

Table of Contents

  1. What Microplastics and Nanoplastics Are
  2. Major Exposure Sources
  3. Body Burden — What Has Been Found and Where
  4. Emerging Health Associations
  5. Proposed Mechanisms
  6. How to Reduce Exposure
  7. Connections

What Microplastics and Nanoplastics Are

Plastics degrade through UV light, mechanical stress, and heat into progressively smaller fragments. Primary microplastics are manufactured small (microbeads, pellet feedstocks). Secondary microplastics form from larger plastics breaking down — tire wear, synthetic-textile laundry fibers, degrading plastic bottles, and plastic food packaging. Below one micrometer the particles are called nanoplastics; they are harder to measure but more biologically active because they can cross cell membranes and the blood-brain barrier.

Major Exposure Sources

Body Burden — What Has Been Found and Where

Emerging Health Associations

The 2024 NEJM atherosclerosis-plaque study is the most robust clinical signal to date: patients with detectable polyethylene and polyvinyl chloride in their carotid plaque had a 4.53-fold higher composite risk of MI, stroke, or death over 34 months compared with patients whose plaques were plastic-free. Associations have also been reported with inflammatory bowel disease severity, reduced sperm parameters, and placental dysfunction. These are preliminary correlations; mechanistic and intervention studies are ongoing.

Proposed Mechanisms

How to Reduce Exposure

The goal is reasonable minimization, not obsession. Simple, high-yield changes:


Connections

↑ Back to Table of Contents